Scarica l'app Stockscreener
293.06
1.61%
-4.79
Dopo l'orario di chiusura:
293.00
-0.06
-0.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$297.85
Aprire:
$301
Volume 24 ore:
6.20M
Relative Volume:
0.94
Capitalizzazione di mercato:
$280.46B
Reddito:
$37.90B
Utile/perdita netta:
$6.20B
Rapporto P/E:
46.08
EPS:
6.36
Flusso di cassa netto:
$12.43B
1 W Prestazione:
-4.95%
1M Prestazione:
-13.61%
6M Prestazione:
+18.14%
1 anno Prestazione:
-7.52%
Intervallo 1D:
$291.06
$303.07
Intervallo di 1 settimana:
$291.06
$313.70
Portata 52W:
$212.00
$369.00
Salesforce Inc Stock (CRM) Company Profile
Nome
Salesforce Inc
Settore
Industria
Telefono
415-901-7000
Indirizzo
SALESFORCE TOWER, SAN FRANCISCO
Confronta CRM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRM
Salesforce Inc
|
293.06 | 280.46B | 37.90B | 6.20B | 12.43B | 6.36 |
|
SAP
Sap Se Adr
|
280.65 | 327.38B | 36.97B | 3.37B | 4.79B | 2.8498 |
|
ADBE
Adobe Inc
|
440.72 | 191.67B | 21.51B | 5.56B | 7.87B | 12.40 |
|
NOW
Servicenow Inc
|
910.31 | 187.97B | 10.98B | 1.43B | 3.38B | 6.83 |
|
INTU
Intuit Inc
|
601.09 | 168.04B | 17.17B | 3.04B | 5.63B | 10.72 |
Salesforce Inc Stock (CRM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-27 | Reiterato | BMO Capital Markets | Outperform |
| 2025-02-19 | Iniziato | Redburn Atlantic | Buy |
| 2025-01-17 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-01-06 | Downgrade | Guggenheim | Neutral → Sell |
| 2024-12-13 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-12-12 | Iniziato | Macquarie | Neutral |
| 2024-12-04 | Reiterato | BMO Capital Markets | Outperform |
| 2024-11-19 | Iniziato | Scotiabank | Sector Outperform |
| 2024-11-15 | Reiterato | BMO Capital Markets | Outperform |
| 2024-10-02 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2024-09-24 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-08-29 | Reiterato | BMO Capital Markets | Outperform |
| 2024-05-30 | Reiterato | Oppenheimer | Outperform |
| 2024-03-21 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2024-01-11 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-12-21 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-12-18 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-11-30 | Reiterato | BMO Capital Markets | Outperform |
| 2023-11-30 | Reiterato | Needham | Buy |
| 2023-11-30 | Reiterato | Oppenheimer | Outperform |
| 2023-10-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-09-15 | Iniziato | HSBC Securities | Buy |
| 2023-07-31 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-01 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-02 | Aggiornamento | Needham | Hold → Buy |
| 2023-01-20 | Downgrade | Cowen | Outperform → Market Perform |
| 2023-01-18 | Iniziato | DA Davidson | Neutral |
| 2023-01-13 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2023-01-11 | Downgrade | Bernstein | Mkt Perform → Underperform |
| 2022-12-08 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-12-02 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2022-11-17 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| 2022-11-02 | Ripresa | Macquarie | Outperform |
| 2022-10-17 | Iniziato | Northland Capital | Market Perform |
| 2022-09-28 | Downgrade | Cleveland Research | Buy → Neutral |
| 2022-09-02 | Aggiornamento | Guggenheim | Sell → Neutral |
| 2022-08-12 | Iniziato | Guggenheim | Sell |
| 2022-05-18 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2022-03-02 | Reiterato | BMO Capital Markets | Outperform |
| 2022-03-02 | Reiterato | BofA Securities | Buy |
| 2022-03-02 | Reiterato | Canaccord Genuity | Buy |
| 2022-03-02 | Reiterato | Piper Sandler | Overweight |
| 2022-03-02 | Reiterato | Raymond James | Strong Buy |
| 2022-03-02 | Reiterato | Stifel | Buy |
| 2022-03-02 | Reiterato | UBS | Neutral |
| 2022-03-02 | Reiterato | Wedbush | Outperform |
| 2022-01-05 | Downgrade | UBS | Buy → Neutral |
| 2021-11-22 | Ripresa | Atlantic Equities | Overweight |
| 2021-11-16 | Iniziato | Credit Suisse | Outperform |
| 2021-11-02 | Iniziato | Deutsche Bank | Buy |
| 2021-09-24 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-09-24 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-09-20 | Iniziato | Wells Fargo | Overweight |
| 2021-08-26 | Reiterato | Barclays | Overweight |
| 2021-08-26 | Reiterato | Bernstein | Mkt Perform |
| 2021-08-26 | Reiterato | BofA Securities | Buy |
| 2021-08-26 | Reiterato | Canaccord Genuity | Buy |
| 2021-08-26 | Reiterato | Citigroup | Neutral |
| 2021-08-26 | Reiterato | Cowen | Outperform |
| 2021-08-26 | Reiterato | Credit Suisse | Outperform |
| 2021-08-26 | Reiterato | FBN Securities | Outperform |
| 2021-08-26 | Reiterato | Mizuho | Buy |
| 2021-08-26 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-08-26 | Reiterato | Oppenheimer | Outperform |
| 2021-08-26 | Reiterato | Piper Sandler | Neutral |
| 2021-08-26 | Reiterato | Stifel | Buy |
| 2021-08-26 | Reiterato | UBS | Buy |
| 2021-07-16 | Ripresa | Stifel | Buy |
| 2021-06-28 | Iniziato | Redburn | Buy |
| 2021-05-28 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-05-19 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-04-23 | Iniziato | Wolfe Research | Outperform |
| 2021-04-05 | Ripresa | Credit Suisse | Outperform |
| 2021-03-16 | Ripresa | Credit Suisse | Outperform |
| 2021-01-25 | Aggiornamento | Loop Capital | Sell → Hold |
| 2021-01-22 | Iniziato | Goldman | Buy |
| 2021-01-11 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Ripresa | BofA Securities | Buy |
| 2020-12-02 | Downgrade | Citigroup | Buy → Neutral |
| 2020-11-24 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-11-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-14 | Ripresa | UBS | Buy |
| 2020-08-26 | Reiterato | Barclays | Overweight |
| 2020-08-26 | Reiterato | Citigroup | Buy |
| 2020-08-26 | Reiterato | Cowen | Outperform |
| 2020-08-26 | Reiterato | Credit Suisse | Outperform |
| 2020-08-26 | Reiterato | JMP Securities | Mkt Outperform |
| 2020-08-26 | Reiterato | Jefferies | Buy |
| 2020-08-26 | Reiterato | Mizuho | Buy |
| 2020-08-26 | Reiterato | Monness Crespi & Hardt | Buy |
| 2020-08-26 | Reiterato | RBC Capital Mkts | Outperform |
| 2020-08-26 | Reiterato | Raymond James | Strong Buy |
| 2020-08-26 | Reiterato | Stifel | Buy |
| 2020-08-26 | Reiterato | Truist | Buy |
| 2020-08-26 | Reiterato | Wedbush | Outperform |
| 2020-08-24 | Reiterato | Barclays | Overweight |
Mostra tutto
Salesforce Inc Borsa (CRM) Ultime notizie
Salesforce CFO Makes Bold Stock Purchase! - TipRanks
Okta delivers what some of its bigger peers couldn’t: a rosy outlook - MarketWatch
Salesforce director Robin Washington buys $499,355 in stock - Investing.com India
All In on AI, Salesforce's Benioff Tells Other CEOs This Is the Last Time They'll Manage Only Humans - Inc.
A Complete Guide To Salesforce Admin Salary In 2025 - Harlem World Magazine
Salesforce Grants Equity Awards to Own Company and Zoomin Employees Under Its Inducement Equity Incentive Plan - Marketscreener.com
Salesforce Gets Big Q4 AI Boost as Agentforce, Data Cloud Boost RPO 11% to $63.4 Billion - Cloud Wars
Flosum Integrates Salesforce’s Agentforce to Transform DevOps Capabilities - SalesforceDevops.net
Salesforce, Inc. (CRM): A Bull Case Theory - Insider Monkey
Investors Heavily Search Salesforce Inc. (CRM): Here is What You Need to Know - Yahoo Finance
Salesforce releases pre-built AI agents to tackle time-consuming healthcare tasks - Fierce healthcare
How Is Salesforce’s Stock Performance Compared to Other Software Stocks? - TradingView
Unified Investment Management Takes Position in Salesforce, Inc. (NYSE:CRM) - MarketBeat
Big CX News from Salesforce, Google, Microsoft & Zoom - CX Today
Salesforce’s Strong Financial Performance and Strategic Initiatives Justify Buy Rating with USD 422 Target Price - TipRanks
Salesforce’s Strong Performance and Growth Potential Highlighted by Buy Rating and $425 Price Target - TipRanks
Optimistic Outlook for Salesforce: Strong Financial Performance and Strategic AI Initiatives Drive Buy Rating - TipRanks
Meta, HP, and Salesforce lead February’s layoff surge: Why is Big Tech cutting jobs? - The Indian Express
Will Agentic AI Be Able to Power Salesforce's Stock Higher in 2025? - The Motley Fool
Nadella vs. Benioff: The real story behind AI’s agentic future - SiliconANGLE News
Salesforce, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsCRM - ACCESS Newswire
Salesforce, Inc. (CRM) Gains Momentum with AI Growth and Strong cRPO Performance - Yahoo Finance
Salesforce, Nvidia, And Snowflake Emerge As Top Stocks - Evrim Ağacı
Salesforce CEO says no plans to hire more engineers, as AI is doing a great job - MSN
Salesforce CEO Marc Benioff says company won't need as many human workers - MSN
Salesforce issues equity awards to new hires from acquisitions By Investing.com - Investing.com South Africa
Salesforce issues equity awards to new hires from acquisitions - Investing.com
Salesforce (CRM) grants equity awards to new employees from Own Company and Zoomin - StreetInsider.com
How Salesforce Is Securing Talent From Its Latest Acquisitions: 218 New Employees Receive Equity - StockTitan
Salesforce Q4 Performance Suggests Investors Should Look Elsewhere (NYSE:CRM) - Seeking Alpha
Salesforce revenue in Q4 flirts with $10 billion mark - Digital Commerce 360
Salesforce won't hire developers because AI works better - Mezha.Media
Analysts raise eyebrows with Salesforce price targets after earnings - TheStreet
Salesforce com : Precina Set to Deliver 24/7, Personalized Diabetes Care Nationally with Agentforce - Marketscreener.com
Microsoft gets dragged (again) by Salesforce CEO Marc Benioff on its multi-billion dollar AI efforts - Windows Central
Avalara Announces Integration for Salesforce Revenue Cloud on Salesforce AppExchange - PR Newswire
Salesforce launches library of ready-made AI tools for healthcare - Healthcare Dive
Salesforce Agentforce AI update targets healthcare - TechTarget
Salesforce to roll out AI for prior authorization - Modern Healthcare
Salesforce: Agentforce Provides The Company With The Keys To The Enterprise AI Kingdom - Seeking Alpha
Salesforce's Hidden Strengths Could Fuel a Powerful Rebound - MSN
Why CRM-King Salesforce May Struggle to Prosper Amid AI Boom - TipRanks
Salesforce’s Hidden Strengths Could Fuel a Powerful Rebound - MarketBeat
HSBC Adjusts Price Target on Salesforce to $411 From $413, Keeps Buy Rating -February 28, 2025 at 05:27 am EST - Marketscreener.com
Citigroup Adjusts Price Target on Salesforce to $335 From $350, Keeps Neutral Rating - Marketscreener.com
Should You Pick Salesforce Stock At $300? - Forbes
Salesforce CEO Marc Benioff makes a ‘DOGE announcement’: Elon Musk’s DOGE team is … - The Times of India
Salesforce, Inc. (NYSE:CRM) Shares Sold by Impax Asset Management Group plc - MarketBeat
Salesforce Achieves Record Revenue Amid Strong Growth - TipRanks
Cathie Wood’s ARK buys Salesforce, Deere stock; sells Spotify, Accolade By Investing.com - Investing.com South Africa
Cathie Wood’s ARK buys Salesforce, Deere stock; sells Spotify, Accolade - Investing.com
Salesforce Inc Azioni (CRM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.05%
2.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):